Where is vifor based?
Switzerland
It is headquartered in Switzerland and consists of Vifor Pharma, Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Sanifit Therapeutics….Vifor Pharma.
| Traded as | SIX: VIFN |
|---|---|
| Industry | Pharmaceutical |
| Founded | 1933 |
| Headquarters | Switzerland |
| Areas served | Worldwide |
What does Vifor Pharma do?
Vifor Pharma aims to be a leader in iron deficiency, nephrology and cardio-renal therapies. We strive to help patients with severe and chronic disease lead better, healthier lives.
How many employees does Vifor Pharma have?
1,250 total
Vifor Pharma AG has 1,250 total employees across all of its locations and generates $2.00 billion in sales (USD).
Is there a generic for Veltassa?
No. There is currently no therapeutically equivalent version of Veltassa available in the United States. Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Veltassa. These medications may be counterfeit and potentially unsafe.
Why is CSL buying vifor?
The biotech launched the offer for Vifor – which makes treatments for iron deficiency conditions and kidney diseases that complement CSL’s product range – in December as it looks to capitalise on the growing obesity epidemic and associated health issues.
Who is Vifor Pharma?
A warm Welcome! Relypsa is now Vifor Pharma. We are a global leader in iron deficiency and iron deficiency anaemia therapies, with a history dating back to 1872, when pharmacist Caspar Friedrich Hausmann opened a pharmacy in St. Gallen, Switzerland. We put patients at the centre of everything we do.
Where can Vifor Pharma clinical research be reported?
Currently, Vifor Pharma clinical research is registered and reported using publicly accessible websites sponsored by the regulatory authorities in the US and Europe.
Is Relypsa now Vifor Pharma?
Vifor Pharma products are present in more than one hundred countries through a unique combination of our commercial operations and collaborations with market-leading partners. A warm Welcome! Relypsa is now Vifor Pharma.